Source: Healthcare Dive
A handful of federal agencies, including CMS, the Office of the National Coordinator and the Food and Drug Administration, have issued targeted regulations around AI use and quality. Some states have also passed health AI legislation. However, Washington has yet to create a concrete strategy for overseeing health AI. That’s expected to change this year, as a new HHS task force works on building a regulatory structure to assess AI before it goes to market and monitor its performance and quality after it does. The task force has “made significant progress” on an overall strategic outline, along with deliverables due by the end of April, including a plan for AI quality and assurance, Syed Mohiuddin, counselor to the deputy secretary of HHS, told Healthcare Dive via email. Mohiuddin is co-leading the task force along with Micky Tripathi, the head of ONC.